Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05927571
Title A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries AUS

Facility Status City State Zip Country Details
The Alfred Hospital RECRUITING Prahan Victoria 3181 Australia Details
Rambam Health Care Campus RECRUITING Haifa 3109600 Israel Details
Sheba Medical Center - PPDS RECRUITING Ramat Gan 5266202 Israel Details
The Catholic University of Korea - Seoul St. Mary's Hospital (Kangnam St. Mary's Hospital) RECRUITING Seocho 06591 Korea, Republic of Details
Seoul National University Hospital RECRUITING Seoul 03080 Korea, Republic of Details
Samsung Medical Center - PPDS RECRUITING Seoul 06351 Korea, Republic of Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field